Against the use of opioids for chronic non-cancer pain to people who have active substance use disorders advises the third recommendation in the new
Two birds with one stone: physicians training in research
Combined training in addiction medicine and research is feasible and acceptable for physicians - a new study shows; however, there are important
Publication Impact of Addiction Clinician-Scientist Fellowship
This study evaluated the impact of an addiction medicine research fellowship. As such, the evaluation here has the potential to radically change
How can we do better job in studying Topiramate?
Topiramate prevents seizures in people with epilepsy. Previously, we looked at all studies to see whether Topiramate can help treat cocaine addiction,
What do persons on methadone in primary care think about alcohol screening?
Enhancing alcohol screening and brief intervention among people receiving opioid agonist treatment: Qualitative study in primary care New Paper Out
XXV Annual Meeting & Canadian Scientific Conference 2015 CSAM – SMCA (#WhatTheFentanyl #abhealth)
What is the future of addiction medicine? What is the future addiction specialist going to look like? Nobody knows what the future is going to look
AMERSA 39th Annual National Conference
November 5th, the national conference of the Association for Medical Education and Research in Addiction - AMERSA 39th - took place in Washington, DC.
Alcohol and Methadone Don’t Mix! What’s New in Addiction Medicine? lecture series
Please join us on Tuesday, October 27 for this month’s edition of the “What’s New in Addiction Medicine?” lecture series. This (free) event
Reduce alcohol consumption in illicit drug users: In the news
In 2012, we reviewed the evidence for talking therapies to reduce drinking among people who also use other drugs. This review was published by the